The Money with Katie Show cover image

The Economics of Weight Loss Drugs, Thinness, and Class Signaling

The Money with Katie Show

CHAPTER

Evolution of GLP-1 Medications

This chapter explores the development and influence of GLP-1 medications like Ozempic and Wegovi in diabetes and weight management. It discusses the historical context, market dynamics, and the role of major pharmaceutical companies, particularly focusing on Novo Nordisk and Eli Lilly. Additionally, it examines societal perceptions of obesity medications, including their benefits, health risks, and the cultural stigma surrounding weight loss interventions.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner